Market Research Logo

Cancer Biomarkers - Global Market Outlook (2016-2022)

Cancer Biomarkers - Global Market Outlook (2016-2022)

According to Stratistics MRC, the Global Cancer Biomarkers market is estimated at $9215.32 million in 2015 and is expected to reach $20958.63 million by 2022 growing at a CAGR of 12.5% from 2015 to 2022. Technological improvements, huge investment flow for Research and Development and increasing usage in drug development and drug delivery are the factors driving the market growth. On the other hand, Sample collection and storage issue and poor reimbursement policies are hampering the market. Growing awareness for personalized medication is the opportunity for the market growth.

North America captured huge share in terms of revenue owing to raising awareness towards cancer diagnostics. However, Asia Pacific is anticipated to be the fastest growing region with highest CAGR during forecast period, because of increasing demand for non invasive diagnosis in this region. The diagnostics segment holds largest share in the market, followed by drug discovery and development.

Some of the key players in the market include Abbott Laboratories, Becton Dickinson and Company, Correlogic Systems, Inc., Agilent Technologies, Biomerieux S.A., Astellas Pharma US Inc., Roche Diagnostics Corp., Astex Pharmaceuticals, Agendia Bv, Diadexus, Inc., Ambrilia Biopharma, CuraGen, Gen-Probe Inc, Beckman Coulter, Inc., Clarient, Inc, Biocurex Inc., and Aureon Laboratories, Inc.,

Services Covered:
Biomakers validation and testing
Sample preparation
Assay development

Diseases Covered:
Lung Cancer
Cervical Cancer
Prostate Cancer
Colorectal Cancer
Breast Cancer
Other Cancers

Profiling Technologies Covered:
Omics Technologies
Transcriptomics
Proteomics
 Protein Microarray Technology
 Peptide Array Technology
 2-D Gel Electrophoresis
 Mass Spectrometry
Imaging Mass Spectrometry
Maldi Mass Spectrometry
 Antibody Array Technology
Genomics
 Microarrays
 Next Generation Sequencing (NGS)
 PCR (Polymer Chain Reaction)
Pharmacogenomics
Metabolomics
Bioinformatics
IVD multivariate index assays
Cytogenetics
DNA microarrays
Ish (In Situ Hybridization)
Immunoassays
Flow Cytometry
Elisa
Immunohistochemistry (IHC)
Imaging Technologies
Mammography
Ultrasound
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Positron Emission Tomography (PET)

Applications Covered:
Risk Assessment
Drug Discovery and Development
Drug formulation
Diagnostics
Prognostics
Other Applications

Types covered:
Genetic Biomarkers
Protein Biomarkers
Other Types
Carbohydrate biomarkers
Cell biomarkers
Viral biomarkers

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.8 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Cancer Biomarkers Market, By Service
5.1 Introduction
5.2 Biomakers validation and testing
5.3 Sample preparation
5.4 Assay development
6 Global Cancer Biomarkers Market, By Disease
6.1 Introduction
6.2 Lung Cancer
6.3 Cervical Cancer
6.4 Prostate Cancer
6.5 Colorectal Cancer
6.6 BreastCancer
6.7 Other Cancers
7 Global Cancer Biomarkers Market, By Profiling Technologies
7.1 Introduction
7.2 Omics Technologies
7.2.1 Transcriptomics
7.2.2 Proteomics
7.2.2.1 Protein Microarray Technology
7.2.2.2 Peptide Array Technology
7.2.2.3 2-D Gel Electrophoresis
7.2.2.4 Mass Spectrometry
7.2.2.4.1 Imaging Mass Spectrometry
7.2.2.4.2 Maldi Mass Spectrometry
7.2.2.5 Antibody Array Technology
7.2.3 Genomics
7.2.3.1 Microarrays
7.2.3.2 Next Generation Sequencing (NGS)
7.2.3.3 PCR (Polymer Chain Reaction)
7.2.4 Pharmacogenomics
7.2.5 Metabolomics
7.3 Bioinformatics
7.4 IVD multivariate index assays
7.5 Cytogenetics
7.5.1 DNA microarrays
7.5.2 Ish (In Situ Hybridization)
7.6 Immunoassays
7.6.1 Flow Cytometry
7.6.2 Elisa
7.6.3 Immunohistochemistry (IHC)
7.7 Imaging Technologies
7.7.1 Mammography
7.7.2 Ultrasound
7.7.3 Magnetic Resonance Imaging (MRI)
7.7.4 Computed Tomography (CT)
7.7.5 Positron Emission Tomography (PET)
8 Global Cancer Biomarkers Market, By Application
8.1 Introduction
8.2 Risk Assessment
8.3 Drug Discovery and Development
8.4 Drug formulation
8.5 Diagnostics
8.6 Prognostics
8.7 Other Applications
9 Global Cancer Biomarkers Market, By Type
9.1 Introduction
9.2 Genetic Biomarkers
9.3 Protein Biomarkers
9.4 Other Types
9.4.1 Carbohydrate biomarkers
9.4.2 Cell biomarkers
9.4.3 Viral biomarkers
10 Global Cancer Biomarkers Market, By Geography
10.1 North America
10.1.1 US
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 UK
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 New Zealand
10.3.6 Rest of Asia Pacific
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Brazil
10.4.3 Argentina
10.4.4 South Africa
10.4.5 Egypt
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Abbott Laboratories,
12.2 Becton Dickinson and Company
12.3 Correlogic Systems, Inc.,
12.4 Agilent Technologies
12.5 Biomerieux S.A.,
12.6 Astellas Pharma US Inc.,
12.7 Roche Diagnostics Corp.
12.8 Astex Pharmaceuticals
12.9 Agendia Bv,
12.10 Diadexus, Inc.,
12.11 Ambrilia Biopharma,
12.12 CuraGen
12.13 Gen-Probe Inc
12.14 Beckman Coulter, Inc.,
12.15 Clarient, Inc,
12.16 Biocurex Inc.,
12.17 Aureon Laboratories, Inc.,
List of Tables
Table 1 Global Cancer Biomarkers Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
Table 3 Global Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
Table 4 Global Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
Table 5 Global Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
Table 6 Global Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
Table 7 Global Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 8 Global Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 9 Global Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 10 Global Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 11 Global Cancer Biomarkers Market Outlook, By BreastCancer (2013-2022) ($MN)
Table 12 Global Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
Table 13 Global Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
Table 14 Global Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
Table 15 Global Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
Table 16 Global Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
Table 17 Global Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
Table 18 Global Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
Table 19 Global Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
Table 20 Global Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
Table 21 Global Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
Table 22 Global Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
Table 23 Global Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
Table 24 Global Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
Table 25 Global Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
Table 26 Global Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
Table 27 Global Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
Table 28 Global Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
Table 29 Global Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
Table 30 Global Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
Table 31 Global Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
Table 32 Global Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
Table 33 Global Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
Table 34 Global Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
Table 35 Global Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
Table 36 Global Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
Table 37 Global Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
Table 38 Global Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
Table 39 Global Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
Table 40 Global Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
Table 41 Global Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
Table 42 Global Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 43 Global Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
Table 44 Global Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
Table 45 Global Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
Table 46 Global Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
Table 47 Global Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
Table 48 Global Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
Table 49 Global Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 50 Global Cancer Biomarkers Market Outlook, By Prognostics (2013-2022) ($MN)
Table 51 Global Cancer Biomarkers Market Outlook, By Other Applications (2013-2022) ($MN)
Table 52 Global Cancer Biomarkers Market Outlook, By Type (2013-2022) ($MN)
Table 53 Global Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2013-2022) ($MN)
Table 54 Global Cancer Biomarkers Market Outlook, By Protein Biomarkers (2013-2022) ($MN)
Table 55 Global Cancer Biomarkers Market Outlook, By Other Types (2013-2022) ($MN)
Table 56 Global Cancer Biomarkers Market Outlook, By Carbohydrate biomarkers (2013-2022) ($MN)
Table 57 Global Cancer Biomarkers Market Outlook, By Cell biomarkers (2013-2022) ($MN)
Table 58 Global Cancer Biomarkers Market Outlook, By Viral biomarkers (2013-2022) ($MN)
Table 59 North America Cancer Biomarkers Market Outlook, By Country (2013-2022) ($MN)
Table 60 North America Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
Table 61 North America Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
Table 62 North America Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
Table 63 North America Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
Table 64 North America Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
Table 65 North America Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 66 North America Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 67 North America Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 68 North America Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 69 North America Cancer Biomarkers Market Outlook, By BreastCancer (2013-2022) ($MN)
Table 70 North America Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
Table 71 North America Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
Table 72 North America Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
Table 73 North America Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
Table 74 North America Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
Table 75 North America Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
Table 76 North America Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
Table 77 North America Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
Table 78 North America Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
Table 79 North America Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
Table 80 North America Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
Table 81 North America Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
Table 82 North America Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
Table 83 North America Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
Table 84 North America Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
Table 85 North America Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
Table 86 North America Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
Table 87 North America Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
Table 88 North America Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
Table 89 North America Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
Table 90 North America Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
Table 91 North America Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
Table 92 North America Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
Table 93 North America Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
Table 94 North America Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
Table 95 North America Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
Table 96 North America Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
Table 97 North America Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
Table 98 North America Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
Table 99 North America Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
Table 100 North America Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 101 North America Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
Table 102 North America Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
Table 103 North America Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
Table 104 North America Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
Table 105 North America Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
Table 106 North America Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
Table 107 North America Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 108 North America Cancer Biomarkers Market Outlook, By Prognostics (2013-2022) ($MN)
Table 109 North America Cancer Biomarkers Market Outlook, By Other Applications (2013-2022) ($MN)
Table 110 North America Cancer Biomarkers Market Outlook, By Type (2013-2022) ($MN)
Table 111 North America Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2013-2022) ($MN)
Table 112 North America Cancer Biomarkers Market Outlook, By Protein Biomarkers (2013-2022) ($MN)
Table 113 North America Cancer Biomarkers Market Outlook, By Other Types (2013-2022) ($MN)
Table 114 North America Cancer Biomarkers Market Outlook, By Carbohydrate biomarkers (2013-2022) ($MN)
Table 115 North America Cancer Biomarkers Market Outlook, By Cell biomarkers (2013-2022) ($MN)
Table 116 North America Cancer Biomarkers Market Outlook, By Viral biomarkers (2013-2022) ($MN)
Table 117 Europe Cancer Biomarkers Market Outlook, By Country (2013-2022) ($MN)
Table 118 Europe Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
Table 119 Europe Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
Table 120 Europe Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
Table 121 Europe Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
Table 122 Europe Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
Table 123 Europe Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 124 Europe Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 125 Europe Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 126 Europe Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 127 Europe Cancer Biomarkers Market Outlook, By BreastCancer (2013-2022) ($MN)
Table 128 Europe Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
Table 129 Europe Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
Table 130 Europe Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
Table 131 Europe Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
Table 132 Europe Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
Table 133 Europe Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
Table 134 Europe Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
Table 135 Europe Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
Table 136 Europe Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
Table 137 Europe Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
Table 138 Europe Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
Table 139 Europe Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
Table 140 Europe Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
Table 141 Europe Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
Table 142 Europe Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
Table 143 Europe Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
Table 144 Europe Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
Table 145 Europe Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
Table 146 Europe Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
Table 147 Europe Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
Table 148 Europe Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
Table 149 Europe Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
Table 150 Europe Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
Table 151 Europe Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
Table 152 Europe Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
Table 153 Europe Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
Table 154 Europe Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
Table 155 Europe Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
Table 156 Europe Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
Table 157 Europe Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
Table 158 Europe Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 159 Europe Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
Table 160 Europe Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
Table 161 Europe Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
Table 162 Europe Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
Table 163 Europe Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
Table 164 Europe Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
Table 165 Europe Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 166 Europe Cancer Biomarkers Market Outlook, By Prognostics (2013-2022) ($MN)
Table 167 Europe Cancer Biomarkers Market Outlook, By Other Applications (2013-2022) ($MN)
Table 168 Europe Cancer Biomarkers Market Outlook, By Type (2013-2022) ($MN)
Table 169 Europe Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2013-2022) ($MN)
Table 170 Europe Cancer Biomarkers Market Outlook, By Protein Biomarkers (2013-2022) ($MN)
Table 171 Europe Cancer Biomarkers Market Outlook, By Other Types (2013-2022) ($MN)
Table 172 Europe Cancer Biomarkers Market Outlook, By Carbohydrate biomarkers (2013-2022) ($MN)
Table 173 Europe Cancer Biomarkers Market Outlook, By Cell biomarkers (2013-2022) ($MN)
Table 174 Europe Cancer Biomarkers Market Outlook, By Viral biomarkers (2013-2022) ($MN)
Table 175 Asia Pacific Cancer Biomarkers Market Outlook, By Country (2013-2022) ($MN)
Table 176 Asia Pacific Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
Table 177 Asia Pacific Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
Table 178 Asia Pacific Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
Table 179 Asia Pacific Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
Table 180 Asia Pacific Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
Table 181 Asia Pacific Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 182 Asia Pacific Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 183 Asia Pacific Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 184 Asia Pacific Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 185 Asia Pacific Cancer Biomarkers Market Outlook, By BreastCancer (2013-2022) ($MN)
Table 186 Asia Pacific Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
Table 187 Asia Pacific Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
Table 188 Asia Pacific Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
Table 189 Asia Pacific Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
Table 190 Asia Pacific Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
Table 191 Asia Pacific Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
Table 192 Asia Pacific Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
Table 193 Asia Pacific Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
Table 194 Asia Pacific Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
Table 195 Asia Pacific Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
Table 196 Asia Pacific Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
Table 197 Asia Pacific Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
Table 198 Asia Pacific Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
Table 199 Asia Pacific Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
Table 200 Asia Pacific Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
Table 201 Asia Pacific Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
Table 202 Asia Pacific Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
Table 203 Asia Pacific Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
Table 204 Asia Pacific Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
Table 205 Asia Pacific Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
Table 206 Asia Pacific Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
Table 207 Asia Pacific Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
Table 208 Asia Pacific Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
Table 209 Asia Pacific Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
Table 210 Asia Pacific Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
Table 211 Asia Pacific Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
Table 212 Asia Pacific Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
Table 213 Asia Pacific Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
Table 214 Asia Pacific Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
Table 215 Asia Pacific Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
Table 216 Asia Pacific Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 217 Asia Pacific Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
Table 218 Asia Pacific Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
Table 219 Asia Pacific Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
Table 220 Asia Pacific Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
Table 221 Asia Pacific Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
Table 222 Asia Pacific Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
Table 223 Asia Pacific Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 224 Asia Pacific Cancer Biomarkers Market Outlook, By Prognostics (2013-2022) ($MN)
Table 225 Asia Pacific Cancer Biomarkers Market Outlook, By Other Applications (2013-2022) ($MN)
Table 226 Asia Pacific Cancer Biomarkers Market Outlook, By Type (2013-2022) ($MN)
Table 227 Asia Pacific Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2013-2022) ($MN)
Table 228 Asia Pacific Cancer Biomarkers Market Outlook, By Protein Biomarkers (2013-2022) ($MN)
Table 229 Asia Pacific Cancer Biomarkers Market Outlook, By Other Types (2013-2022) ($MN)
Table 230 Asia Pacific Cancer Biomarkers Market Outlook, By Carbohydrate biomarkers (2013-2022) ($MN)
Table 231 Asia Pacific Cancer Biomarkers Market Outlook, By Cell biomarkers (2013-2022) ($MN)
Table 232 Asia Pacific Cancer Biomarkers Market Outlook, By Viral biomarkers (2013-2022) ($MN)
Table 233 RoW Cancer Biomarkers Market Outlook, By Country (2013-2022) ($MN)
Table 234 RoW Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
Table 235 RoW Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
Table 236 RoW Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
Table 237 RoW Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
Table 238 RoW Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
Table 239 RoW Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 240 RoW Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 241 RoW Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 242 RoW Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 243 RoW Cancer Biomarkers Market Outlook, By BreastCancer (2013-2022) ($MN)
Table 244 RoW Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
Table 245 RoW Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
Table 246 RoW Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
Table 247 RoW Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
Table 248 RoW Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
Table 249 RoW Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
Table 250 RoW Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
Table 251 RoW Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
Table 252 RoW Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
Table 253 RoW Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
Table 254 RoW Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
Table 255 RoW Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
Table 256 RoW Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
Table 257 RoW Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
Table 258 RoW Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
Table 259 RoW Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
Table 260 RoW Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
Table 261 RoW Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
Table 262 RoW Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
Table 263 RoW Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
Table 264 RoW Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
Table 265 RoW Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
Table 266 RoW Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
Table 267 RoW Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
Table 268 RoW Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
Table 269 RoW Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
Table 270 RoW Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
Table 271 RoW Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
Table 272 RoW Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
Table 273 RoW Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
Table 274 RoW Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 275 RoW Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
Table 276 RoW Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
Table 277 RoW Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
Table 278 RoW Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
Table 279 RoW Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
Table 280 RoW Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
Table 281 RoW Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report